152 related articles for article (PubMed ID: 1284196)
1. Vimentin expression in benign and malignant lesions in the human mammary gland.
Wada T; Yasutomi M; Hashmura K; Kunikata M; Tanaka T; Mori M
Anticancer Res; 1992; 12(6B):1973-82. PubMed ID: 1284196
[TBL] [Abstract][Full Text] [Related]
2. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
Joshi MG; Lee AK; Pedersen CA; Schnitt S; Camus MG; Hughes KS
Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
[TBL] [Abstract][Full Text] [Related]
3. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of cytokeratins characteristic for myoepithelial and luminal cell lineages in rat 13762NF mammary adenocarcinoma tumors and their spontaneous metastases.
Lichtner RB; Julian JA; North SM; Glasser SR; Nicolson GL
Cancer Res; 1991 Nov; 51(21):5943-50. PubMed ID: 1718590
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of keratin expression and actin distribution in benign and malignant mammary diseases.
Wada T; Yasutomi M; Yamada K; Hashimura K; Kunikata M; Tanaka T; Huang JW; Mori M
Anticancer Res; 1991; 11(6):1983-93. PubMed ID: 1723260
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
Pellegrino MB; Asch BB; Connolly JL; Asch HL
Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
[TBL] [Abstract][Full Text] [Related]
7. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions.
Dalal P; Shousha S
Mod Pathol; 1995 May; 8(4):413-6. PubMed ID: 7567941
[TBL] [Abstract][Full Text] [Related]
8. Keratin and vimentin distribution patterns in the epithelial structures of the canine anal region.
Vos JH; van den Ingh TS; Ramaekers FC; de Neijs M; van Mil FN; Ivanyi D
Anat Rec; 1992 Nov; 234(3):391-8. PubMed ID: 1280011
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium.
Raymond WA; Leong AS
J Pathol; 1989 Apr; 157(4):299-306. PubMed ID: 2469782
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer.
Guelstein VI; Tchypysheva TA; Ermilova VD; Litvinova LV; Troyanovsky SM; Bannikov GA
Int J Cancer; 1988 Aug; 42(2):147-53. PubMed ID: 2456993
[TBL] [Abstract][Full Text] [Related]
11. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.
Altemani A; Martins MT; Freitas L; Soares F; Araújo NS; Araújo VC
Histopathology; 2005 Jun; 46(6):635-41. PubMed ID: 15910594
[TBL] [Abstract][Full Text] [Related]
13. [Location of epi-myoepithelial markers (EMA, keratin, protein S-100) and connective tissue markers (vimentin) in carcinoma with pseudosarcomatous metaplasia of the human breast. A study of 3 cases using a dual color immunohistochemical technic].
Lanzafame S; Puzzo L; Gangemi P
Pathologica; 1987; 79(1062):469-82. PubMed ID: 2453833
[No Abstract] [Full Text] [Related]
14. Heterogeneity and co-expression of intermediate filament proteins in adenoid cystic carcinoma of salivary glands.
Chomette G; Auriol M; Vaillant JM; Kasai T; Okada Y; Mori M
Pathol Biol (Paris); 1991 Feb; 39(2):110-6. PubMed ID: 1708120
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratins as markers of initial stages of squamous metaplasia in feline mammary carcinomas.
Ivanyi D; Minke JM; Hageman C; Groeneveld E; van Doornewaard G; Misdorp W
Am J Vet Res; 1993 Jul; 54(7):1095-102. PubMed ID: 7690208
[TBL] [Abstract][Full Text] [Related]
16. [Medullary carcinoma of the breast. Co-expression of keratin intermediate filaments and protein S-100 in tumor cells].
Puzzo L; Lanzafame S
Pathologica; 1989; 81(1074):433-9. PubMed ID: 2483260
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratins 7 and 14 in special types of invasive breast carcinomas.
Toth T
Med Pregl; 1999; 52(6-8):227-32. PubMed ID: 10518377
[TBL] [Abstract][Full Text] [Related]
18. [Monoclonal antibodies to the proteins of intermediate filaments and of basement membranes in the differential diagnosis of certain forms of human breast tumors].
Gel'shteĭn VI; Chipysheva TA; Ermilova VD; Liubimov AV
Arkh Patol; 1990; 52(9):12-8. PubMed ID: 1702969
[TBL] [Abstract][Full Text] [Related]
19. p53 expression in cytologic specimens from benign and malignant breast lesions.
Koutselini H; Malliri A; Field JK; Spandidos DA
Anticancer Res; 1991; 11(4):1415-9. PubMed ID: 1746898
[TBL] [Abstract][Full Text] [Related]
20. p63 is useful in the diagnosis of mammary metaplastic carcinomas.
Tse GM; Tan PH; Chaiwun B; Putti TC; Lui PC; Tsang AK; Wong FC; Lo AW
Pathology; 2006 Feb; 38(1):16-20. PubMed ID: 16484002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
